Ravindrakumar Gangadhariah
Dermatology · Davenport, IANPI 1922047869
Payments from drug & device makers
What this record shows
This record is dominated by other: $15,792 of the $19,741 with a category attached, or 80.0%. Biofrontera Inc. accounts for 80.1% of it on its own, with 27 other manufacturers making up the rest. 2024 is the largest year on record at $15,792, more than ten times the $669 reported in 2019. Among dermatology clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 216 payments — averaging $91.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biofrontera Inc.$16K
- AbbVie$1K
- UCB, Inc.$551
- Johnson & Johnson$372
- Janssen Scientific Affairs, LLC$250
- Amgen$224
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,82619%
- Education$1231%
- Other$15,79280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biofrontera Inc. | 2 | $15,805 |
| AbbVie | 56 | $1,139 |
| UCB, Inc. | 33 | $551 |
| Johnson & Johnson | 23 | $372 |
| Janssen Scientific Affairs, LLC | 2 | $250 |
| Amgen | 15 | $224 |
| Sun Pharmaceutical Industries Inc. | 13 | $218 |
| Regeneron Healthcare Solutions, Inc. | 10 | $156 |
| Pfizer | 8 | $141 |
| LEO Pharma Inc. | 6 | $121 |
| Sanofi | 8 | $118 |
| Incyte Corporation | 5 | $83 |
| VYNE Pharmaceuticals Inc. | 4 | $70 |
| Lilly USA, LLC | 4 | $61 |
| E.r. Squibb & Sons, L.L.C. | 4 | $61 |
| Melinta Therapeutics, LLC | 4 | $56 |
| Galderma Laboratories, L.p. | 3 | $48 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Kyowa Kirin, Inc. | 2 | $37 |
| Encore Dermatology Inc. | 2 | $33 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| Prugen, Inc. Pharmaceuticals | 1 | $19 |
| Nabriva Therapeutics, PLC | 1 | $19 |
| Novartis | 1 | $19 |
| Dermira, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| Strata Skin Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMELUZ$15,792
- BF-RhodoLED$15,792
- RhodoLED XL$15,792
- Tremfya$250
- Skyrizi$120
How this compares
$19,741 in reported general payments places this provider in the 90th percentile of 92 dermatology providers in Iowa.
Other dermatology in Davenport
- Jordan EvansDavenport$3K
- Jill LightfootDavenport$3K
- William ColantoniDavenport$1K
- Roger CeilleyWest Des Moines$82K
- David KnutsonCedar Rapids$60K
- Scott GreenFort Dodge$56K
- Timothy AbrahamsonUrbandale$49K
- Ali JabbariIowa City$38K
- Somaira NowsheenWaukee$15K
- Laura MyersAnkeny$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.